Lataa...
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?
Background: The comorbidities and clinical signs of coronavirus disease 2019 (COVID-19) patients have been reported mainly as descriptive statistics, rather than quantitative analysis even in very large investigations. The aim of this study was to identify specific patients’ characteristics that may...
Tallennettuna:
| Julkaisussa: | Expert Rev Respir Med |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752139/ https://ncbi.nlm.nih.gov/pubmed/33183113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17476348.2021.1850275 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|